Signos raises $20 million from Google Ventures, Dexcom and Blue Cross Blue Shield of Alabama to expand its glucose monitoring platform.

Signos, maker of an FDA-cleared, over-the-counter wearable that monitors glucose, has raised $20 million to accelerate growth. The round includes backing from Google Ventures, Dexcom and Blue Cross Blue Shield of Alabama via 450 Ventures.

2h ago · 1 source